首页 › 基金 › ArrowMark Colorado Holdings LLC › ABCL
ArrowMark Colorado Holdings LLC 对 ABCL 的持仓历史
ABCELLERA BIOLOGICS INC · 医疗保健
ArrowMark Colorado Holdings LLC 在 Q2 2026 的 13F 申报中披露持有 ABCL(ABCELLERA BIOLOGICS INC)4,105,095 股,市值约 US$32.2M,约占其申报组合的 1.34%,在其申报持仓中市值排名第 5 位。 ArrowMark Colorado Holdings LLC 最近 12 个申报季度中有 12 个季度披露了 ABCL 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
ArrowMark Colorado Holdings LLC 对 ABCL 的持仓演变
ArrowMark Colorado Holdings LLC 于 Q3 2023 首次披露 ABCL 持仓:4,105,095 股(约 US$18.9M)。 该持仓在 Q2 2026 达到峰值 4,105,095 股,市值约 US$32.2M。 在 12 次申报中,ArrowMark Colorado Holdings LLC 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 4,105,095 股、市值约 US$32.2M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 4.11M | $18.88M | 新进 |
| Q4 2023 | 4.11M | $23.44M | 持有 |
| Q1 2024 | 4.11M | $18.60M | 持有 |
| Q2 2024 | 4.11M | $12.15M | 持有 |
| Q3 2024 | 4.11M | $10.67M | 持有 |
| Q4 2024 | 4.11M | $12.03M | 持有 |
| Q1 2025 | 4.11M | $9.15M | 持有 |
| Q2 2025 | 4.11M | $14.08M | 持有 |
| Q3 2025 | 4.11M | $20.65M | 持有 |
| Q4 2025 | 4.11M | $14.04M | 持有 |
| Q1 2026 | 4.11M | $14.33M | 持有 |
| Q2 2026 | 4.11M | $32.22M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ABCL 与 13F 数据
ABCL(ABCELLERA BIOLOGICS INC)属于医疗保健行业。我们追踪的基金中还有 37 只申报持有 ABCL,申报仓位最大的包括:BAKER BROS. ADVISORS LP (US$259.1M), Guardian Partners Inc. (US$8.7M), Intellectus Partners, LLC (US$4.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ABCL 的基金
- BAKER BROS. ADVISORS LP 33.01M 股 · $259.15M · Q2 2026
- Guardian Partners Inc. 596.00K 股 · $8.70M · Q3 2026
- Intellectus Partners, LLC 551.58K 股 · $4.33M · Q2 2026
- SOFTBANK GROUP CORP. 345.16K 股 · $2.71M · Q2 2026
更多关于 ArrowMark Colorado Holdings LLC
常见问题
How long has ArrowMark Colorado Holdings LLC held ABCL?
ArrowMark Colorado Holdings LLC has disclosed ABCL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is ArrowMark Colorado Holdings LLC's current position in ABCL?
As of Q2 2026, ArrowMark Colorado Holdings LLC holds 4.11M shares of ABCL (ABCELLERA BIOLOGICS INC), valued at $32.22M, representing 1.34% of its reported portfolio and ranking #5.
Has ArrowMark Colorado Holdings LLC been buying or selling ABCL?
In the latest 13F filing (Q2 2026), ArrowMark Colorado Holdings LLC held unchanged its position in ABCL. The position peaked in Q2 2026 at 4.11M shares.
Which other funds hold ABCL?
Other major institutional holders of ABCL include BAKER BROS. ADVISORS LP, Guardian Partners Inc., Intellectus Partners, LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.